Catheter Outcomes With Sternotomy Cardiac Operated

PHASE3CompletedINTERVENTIONAL
Enrollment

1,502

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
PneumoniaCardiac SurgeryMultiperforated CatheterAnalgesiaCritical Care Medicine
Interventions
DEVICE

L bupivacaine

"L-bupivacain solution CHIROCAINE® 5mg/ml, flakon de 20 ml): for the intravenous bolus of 10 ml~o (CHIROCAINE®1.25mg/ml, 200 mL/unit, 400 ml in the accufusor infused at 8ml/h during 48h00: for infusion during 48h00"

DRUG

placebo

"* Isotonic NaCl solution (9°/00) solution: for the intravenous bolus of 10 ml~* Isotonic NaCl solution (9°/00) solution, 400 ml in the accufusor infused at 8ml/h during 48h00: for infusion during 48h00"

Trial Locations (1)

75013

Pitié salpetrière Hospital, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

collaborator

WYM France

UNKNOWN

collaborator

Abbott

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER